DaVita HealthCare Partners Inc. (DVA) Scheduled to Post Earnings on Tuesday
DaVita HealthCare Partners Inc. (NYSE:DVA) is scheduled to be releasing its earnings data after the market closes on Tuesday, August 1st. Analysts expect DaVita HealthCare Partners to post earnings of $0.90 per share for the quarter.
DaVita HealthCare Partners (NYSE:DVA) last released its earnings results on Tuesday, May 2nd. The company reported $0.79 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by $0.03. DaVita HealthCare Partners had a return on equity of 14.85% and a net margin of 8.28%. The company had revenue of $3.70 billion during the quarter, compared to analysts’ expectations of $3.69 billion. On average, analysts expect DaVita HealthCare Partners to post $3.49 EPS for the current fiscal year and $3.81 EPS for the next fiscal year.
Shares of DaVita HealthCare Partners Inc. (NYSE DVA) opened at 65.48 on Tuesday. The stock has a market cap of $12.74 billion, a P/E ratio of 10.75 and a beta of 0.89. The firm has a 50-day moving average of $64.75 and a 200-day moving average of $66.03. DaVita HealthCare Partners Inc. has a 52-week low of $54.50 and a 52-week high of $78.40.
Several research analysts have recently weighed in on DVA shares. TheStreet upgraded shares of DaVita HealthCare Partners from a “c+” rating to a “b-” rating in a report on Monday, April 3rd. Zacks Investment Research upgraded shares of DaVita HealthCare Partners from a “hold” rating to a “buy” rating and set a $77.00 price target for the company in a report on Tuesday, April 18th. Jefferies Group LLC set a $70.00 price target on shares of DaVita HealthCare Partners and gave the company a “buy” rating in a report on Friday, May 26th. BidaskClub cut shares of DaVita HealthCare Partners from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Finally, Goldman Sachs Group, Inc. (The) reiterated a “sell” rating and issued a $62.00 price target on shares of DaVita HealthCare Partners in a report on Thursday, May 25th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. DaVita HealthCare Partners has an average rating of “Hold” and a consensus price target of $69.50.
COPYRIGHT VIOLATION NOTICE: “DaVita HealthCare Partners Inc. (DVA) Scheduled to Post Earnings on Tuesday” was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2017/07/25/davita-healthcare-partners-inc-dva-scheduled-to-post-earnings-on-tuesday.html.
In related news, Director Charles Berg sold 8,414 shares of the stock in a transaction on Tuesday, May 9th. The shares were sold at an average price of $65.80, for a total transaction of $553,641.20. Following the completion of the transaction, the director now owns 34,719 shares in the company, valued at $2,284,510.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William L. Roper sold 12,994 shares of the stock in a transaction on Thursday, May 4th. The stock was sold at an average price of $65.89, for a total transaction of $856,174.66. Following the transaction, the director now owns 45,277 shares of the company’s stock, valued at approximately $2,983,301.53. The disclosure for this sale can be found here. Insiders have sold 22,702 shares of company stock valued at $1,495,492 in the last 90 days. 2.00% of the stock is currently owned by corporate insiders.
About DaVita HealthCare Partners
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Receive News & Ratings for DaVita HealthCare Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.